APS E-News | Advocacy Update Report | August 2018
Trump Administration Wants Drugmakers To Reduce Production Quotas For Six Opioids
The Trump Administration has proposed that U.S. drugmakers cut production quotas of the six most abused opioids by 10 percent next year. The Department of Justice and the Drug Enforcement Administration (DEA) are proposing to cut production quotas for oxycodone, hydrocodone, oxymorphone, hydromorphone, morphine, and fentanyl by 7 percent to 15 percent in 2019, depending on the compound.
According to The Hill, Acting DEA Administrator Uttam Dhillon said “[the significant decline] in prescriptions by doctors and DEA’s production quota adjustment will continue to reduce the amount of drugs available for illicit diversion and abuse while ensuring that patients will continue to have access to proper medicine.”
